AstraZeneca has entered into an exclusive license agreement with China-based Dizal Pharmaceutical for Zegfrovy ...
India's Sai Parenterals has announced that its Australian subsidiary, Noumed Pharmaceuticals, has successfully renewed i...
How does CT fit into your overall regional expansion strategy, especially in emerging markets like India and Southeast A...
Canada-based ExCellThera Inc., a global leader in blood stem cell expansion and metabolic fitness technologies and paren...
Drug development is approaching a significant inflection point. Advances in induced pluripotent stem cells (iPSCs), orga...
Japan-based Dai Nippon Printing (DNP) has signed a share purchase agreement to acquire Kyowa Pharma Chemical, an act...
US-based Organon, a global healthcare company with deep expertise in biosimilars, and Korea's Samsung Bioepis have annou...
Cell therapy is approaching a defining transition: from highly specialised science to a reproducible, scalable pharmaceu...
The pharmaceutical industry’s innovation equation is changing. Developing an entirely new molecu...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
As BioSpectrum Asia reports on the ground from BIO Asia–Taiwan 2026, being held from July 15–19 in T...
Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treat...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
As gene therapy moves from scientific promise towards a new phase of commercial maturity, manufacturing has emerged as o...
Longevity has never had a science problem so much as a business model problem. No regulator anywhere approves a drug for...
Every host city wants the same thing from an event like this: not the visit, but the verdict. What made the press meet w...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
US-based GEM Global Yield LLC SCS has executed a Share Purchase Agreement (SPA) with the existing shareholders of Taiwan...
South Korea-based startup Boostimmune has secured a Japanese patent covering technology that uses antibodies to inhibit ...
Japan-based Shimadzu Corporation has completed the acquisition of all shares of Glass HoldCo s.r.o., which indirectly ho...
China-based startup OTR Therapeutics has entered into a strategic collaboration agreement with Korean company LG Chem to...
There is a particular energy to the first thirty minutes of a conference that knows exactly what it wants to say. As the...
South Korea-based Samsung Bioepis has entered into a license agreement with Proteina Co. to collaborate on a government-...
As gastroenterology providers across Australia and New Zealand face growing patient demand and increasing documentation ...
South Korea-based Daewoong Pharmaceutical has entered into a distribution agreement with Waycen Inc., a medical AI compa...
